Charles Schwab
PRVA icon

Charles Schwab’s Privia Health PRVA Stock Holding History

Charles Schwab’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.4M Buy
1,374,828
+55,722
+4% +$1.29M ﹤0.01% 1471
2026
Q1 		$27.1M Buy
1,319,106
+39,765
+3% +$896K ﹤0.01% 1557
2025
Q4 		$30.3M Buy
1,279,341
+1,955
+0.2% +$47.6K ﹤0.01% 1490
2025
Q3 		$31.8M Buy
1,277,386
+71,245
+6% +$1.53M 0.01% 1448
2025
Q2 		$27.7M Buy
1,206,141
+13,779
+1% +$319K ﹤0.01% 1478
2025
Q1 		$26.8M Buy
1,192,362
+58,489
+5% +$1.36M 0.01% 1458
2024
Q4 		$22.2M Buy
1,133,873
+69,649
+7% +$1.38M ﹤0.01% 1649
2024
Q3 		$19.4M Buy
1,064,224
+65,152
+7% +$1.24M ﹤0.01% 1712
2024
Q2 		$17.4M Buy
999,072
+73,221
+8% +$1.3M ﹤0.01% 1765
2024
Q1 		$18.1M Buy
925,851
+73,260
+9% +$1.55M ﹤0.01% 1670
2023
Q4 		$19.6M Buy
852,591
+29,835
+4% +$668K 0.01% 1608
2023
Q3 		$18.9M Buy
822,756
+136,660
+20% +$3.48M 0.01% 1535
2023
Q2 		$17.9M Buy
686,096
+289,758
+73% +$7.65M 0.01% 1573
2023
Q1 		$10.9M Buy
396,338
+15,592
+4% +$412K ﹤0.01% 1823
2022
Q4 		$8.65M Buy
380,746
+15,276
+4% +$425K ﹤0.01% 1947
2022
Q3 		$12.4M Buy
365,470
+136,706
+60% +$5.06M ﹤0.01% 1696
2022
Q2 		$6.66M Buy
228,764
+3,152
+1% +$80.1K ﹤0.01% 2051
2022
Q1 		$6.03M Buy
225,612
+59,925
+36% +$1.41M ﹤0.01% 2190
2021
Q4 		$4.29M Buy
165,687
+24,936
+18% +$622K ﹤0.01% 2427
2021
Q3 		$3.32M Buy
140,751
+3,207
+2% +$112K ﹤0.01% 2565
2021
Q2 		$6.1M Buy
+137,544
New +$5.07M ﹤0.01% 2247

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Charles Schwab's PRVA Position: Q2 2026 in Review

Charles Schwab increased its Privia Health (PRVA) stake by 4.2% in Q2 2026, buying an estimated $1.29M and bringing the position to 1,374,828 shares worth $35.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Charles Schwab first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Charles Schwab held 1,374,828 shares of Privia Health worth $35.4M as of Q2 2026.
  • Charles Schwab bought 55,722 Privia Health shares in Q2 2026, an estimated $1.29M.
  • Privia Health made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1471 holding.
  • Charles Schwab first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.